Skip to main content

Table 3 The number of patients with the adverse effects in the N-Acetylcysteine + risperidone group and Placebo+risperidone group

From: A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders

Adverse effect N-Acetylcysteine + risperidone group Placebo+risperidone group
Number Percent Number Percent
Daytime drowsiness 4 12.9 2 6.5
Morning drowsiness 1 3.2 0 0
Stiffness 2 6.5 0 0
Slowed movement 2 6.5 0 0
Decreased Appetite 1 3.2 - 0
Fatigue 4 12.9 4 3.2
Constipation 5 16.1 1 3.2
Increased appetite 5 16.1 3 9.7
Decreased appetite 2 6.5 1 3.2
Diarrhea 0 0 1 3.2
Tremor 2 6.5 0 0
Abdominal pain 1 3.2 0 0
Nervousness 4 12.9 0 0
Itches 1 3.2 1 3.2
Restlessness 2 6.5 2 6.5
Twitches 1 3.2 0 0
Blurred vision 1 3.2 0 0
Urinary retention 0 0 0 0
Dizziness 0 0 0 0
Skin rash 0 0 0 0
Itches 0 0 0 0
Dry mouth 0 0 0 0
Swallowing difficulty 0 0 0 0
Seizure 0 0 0 0